The US Lymphedema Market (2017-2021 Edition), provides analysis of the US lymphedema market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The report also provides the analysis of the US Pneumatic Compression Device (PCD) market, by value, by device adoption, by players, etc. —
Furthermore, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall US lymphedema market has also been forecasted for the years 2017-2021, taking into consideration the previous growth pattern, the growth drivers and the current and future trends.
Company Profiling are Tactile Medical, Bio Compression System, Lympha Press (Mego Afek) and Wright Therapy Products (BSN Medical).
Order a copy of this research report ($700) at https://www.marketinsightsreports.com/report/purchase/10121015?mode=su
Lymphedema is when excess lymphatic fluid gets collected in the tissues under the skin, which causes swelling. Generally, lymphedema occurs due to the damage or removal of lymph nodes, as a part of cancer surgery.
Tactile is the only company providing the Advanced PC device, named Flexitouch. The other key companies in the market are Bio Compression System, Wright Therapy Products and Lympha Press, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.
Lymphedema can be divided into 4 stages, based on the swelling it causes and its severity. There are two types of lymphedema: Primary Lymphedema and Secondary Lymphedema. Primary lymphedema is detected in the children and it is generally the result of an error in the development of the lymphatic system. Secondary lymphedema represents more than 99% of the total cases. It occurs due to the cancer treatment or surgery, resulting in the removal of lymph nodes.
Complete report of 41 pages with TOC is available at https://www.marketinsightsreports.com/reports/10121015/the-us-lymphedema-market-2017-to-2021-edition
There are many options of treatment of lymphedema available today. These can be used as a single option, and/or in combinations. Treatment of Lymphedema includes: Controlled Compression Therapy, Manual Lymph Drainage (MLD), Complete Decongestive Therapy (CDT) and Pneumatic Compression (PC). PCD are the devices which deliver intermittent pressure through varying inflation and deflation chambers, to move the lymph fluid from extremity and to avoid the adverse consequences of uncontrolled lymphedema.
List of Figures
Figure 1: Type of Lymphedema
Figure 2: Treatment of Lymphedema
Figure 3: Total US Population; 2015-2021 (Million)
Figure 4: The US Lymphedema Market by Number of Patients and Penetration; 2015-2021
Figure 5: The US Lymphedema Market by Number of Patients Diagnosed; 2015-2016
Figure 6: The US Lymphedema Market by Number of Patients Diagnosed; 2017-2021
Figure 7: The US Lymphedema Market by Number of Diagnosed Patients Severity; 2015-2016
Figure 8: The US Lymphedema Market by Number of Diagnosed Patients Severity; 2017-2021
Figure 9: The US Lymphedema Market by Total Addressable Market (TAM); 2015-2016 (US$ Million)
Figure 10:The US Lymphedema Market by Total Addressable Market (TAM); 2017-2021 (US$ Million)
Figure 11: The US Lymphedema Patients by Causes
Figure 12: The US Lymphedema Patients by Gender
Figure 13: The US Lymphedema Patients by Age Group
Figure 14: The US PCD Market by Case Adoption; 2016-2021
Figure 15: The US PCD Market by ASP; 2015-2016(US$)
Figure 16: The US PCD Market by ASP; 2017-2021(US$)
Figure 17: The US PCD Market by Value; 2016-2021 (US$ Million)
Figure 18: The US PCD Market Share by Players; 2016-2021
Figure 19: Tactile Revenue; 2013-2016 (US$ Million)
Figure 20: Tactile Revenue by Segments; 2016
Name: Diane Conrad
Email: Send Email
Organization: Market Insights Reports
Release ID: 249404